Russian CRO Atlant Clinical continues to grow 'despite certain political and economic challenges’

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/hansslegers)
(Image: Getty/hansslegers)
The Russia-based CRO Atlant Clinical has received certification in the organization and management of clinical trials – demand for which continues to increase despite political and economic challenges.

Atlant Clinical has received ISO 9001:2015​ certification in the organization and management of clinical trials. According to the company, it is the first and only contract research organization (CRO) in Russia to be granted the certification after successfully passing the Bureau Veritas audit.

The company received ISO 9001:2008​ certification in 2015. 

Marietta Sarkisyan, business development and marketing manager, Atlant Clinical, said the certification highlights the “quality and compliance of all operations of Atlant Clinical”​ and “certifies that all work is done in accordance with the best international practices.” 

The CRO operates not only in Russia, but also in Eastern and Western Europe, the US, Baltics, and ex-USSR markets, Sarkisyan said. “We do not see decline of demand for our services in Russia as we have been on the market for over 10 years and have excellent reputation with both our sponsors and other pharmaceutical and biotech companies,”​ she told us.

Atlant’s repeat business rate is well above 80%, Sarkisyan explained, “so our Russian turnover continues to grow despite certain political and economic challenges.”

“We constantly work on increasing our European and North American business, so share of Russian projects in our portfolio gradually declines,”​ she added.

As the company develops, Sarkisyan said it is able to take on more challenging and comprehensive international projects. “We now have more trials that cover 10+ countries,” ​she added, “and we see more projects from global pharmaceutical and biotech firms.”

These projects are larger and drive the company’s revenue numbers up, explained Sarkisyan. “Finally, we have long-term contracts with some of our clients, where we provide ongoing clinical and other professional support.”

Related news

Show more

Related products

show more

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 16-Jan-2023 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Optimizing Adherence in DCTs

Optimizing Adherence in DCTs

PPD - Decentralized Clinical Trials | 12-Jan-2023 | Technical / White Paper

Prioritizing greater patient-centricity and creating an opportunity to reach unprecedented patient groups, decentralized and hybrid clinical trials are...

PPD is Supporting Complex EU DCTs

PPD is Supporting Complex EU DCTs

PPD - Decentralized Clinical Trials | 05-Jan-2023 | Technical / White Paper

PPD supports European DCTs and clinical trial sponsors with a holistic and comprehensive approach

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 14-Dec-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us


View more